Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

421 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Colorectal Cancer Non-Protocol Therapy NCT00303628 - Non-Protocol Therapy Colorectal Cancer NCT00303628 E5204

- 25/03/15 - 1 modulo, 2 itemgroups, 25 elementi, 1 linguaggio
Itemgroups: Header, Non-Protocol Therapy
E5204 Non-Protocol Therapy Form Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer NCT00303628 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=089B4967-A7D1-3905-E044-0003BA3F9857

Eligibility Colorectal Cancer NCT00625625

- 17/11/21 - 1 modulo, 1 ItemGroup, 22 elementi, 1 linguaggio
ItemGroup: Criteria
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00625625

Eligibility Colorectal Cancer NCT00995202

- 20/09/21 - 1 modulo, 1 ItemGroup, 14 elementi, 1 linguaggio
ItemGroup: Criteria
Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00995202

Eligibility Colorectal Cancer NCT00713128

- 20/09/21 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-based Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00713128

Eligibility Colorectal Cancer NCT00755534

- 20/09/21 - 1 modulo, 2 itemgroups, 20 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC; ODM derived from: https://clinicaltrials.gov/show/NCT00755534

Eligibility Colorectal Cancer NCT00819169

- 20/09/21 - 1 modulo, 2 itemgroups, 9 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00819169

Eligibility Colorectal Cancer NCT00551213

- 20/09/21 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study to Determine the Activity of SCH 717454 in Subjects With Relapsed or Recurrent Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00551213

Eligibility Colorectal Cancer NCT00893503

- 20/09/21 - 1 modulo, 2 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Scope Pilot Research Study; ODM derived from: https://clinicaltrials.gov/show/NCT00893503

Eligibility Colorectal Cancer Screening NCT02481219

- 20/09/21 - 1 modulo, 2 itemgroups, 18 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure; ODM derived from: https://clinicaltrials.gov/show/NCT02481219

Eligibility Metastatic Colorectal Cancer NCT02503150

- 20/09/21 - 1 modulo, 2 itemgroups, 16 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02503150

Colorectal cancer metastases (NCT00268463) - Quality of Life Form Colorectal Cancer (NSABP C-09 NCT00268463)

- 20/09/21 - 1 modulo, 8 itemgroups, 94 elementi, 1 linguaggio
Itemgroups: Header, Treatment satisfaction, PHYSICAL WELL-BEING, Social and family well being, EMOTIONAL WELL-BEING, Functional Health, ADDITIONAL CONCERNS, Activity
NSABP Protocol C-09: Quality of Life Form Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer NCT00268463 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FC7E0FCB-064A-58CD-E034-0003BA3F9857

Eligibility NCT00932724 Metastatic Colorectal Cancer - Eligibility

- 20/09/21 - 1 modulo, 2 itemgroups, 25 elementi, 2 lingue
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00932724

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial